"Androstadienes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of the steroid androstane having two double bonds at any site in any of the rings.
Below are MeSH descriptors whose meaning is more general than "Androstadienes".
Below are MeSH descriptors whose meaning is more specific than "Androstadienes".
This graph shows the total number of publications written about "Androstadienes" by people in Harvard Catalyst Profiles by year, and whether "Androstadienes" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 7 | 9 |
| 1996 | 2 | 8 | 10 |
| 1997 | 3 | 10 | 13 |
| 1998 | 2 | 6 | 8 |
| 1999 | 0 | 7 | 7 |
| 2000 | 0 | 6 | 6 |
| 2001 | 0 | 12 | 12 |
| 2002 | 4 | 6 | 10 |
| 2003 | 0 | 9 | 9 |
| 2004 | 3 | 6 | 9 |
| 2005 | 3 | 5 | 8 |
| 2006 | 1 | 6 | 7 |
| 2007 | 4 | 4 | 8 |
| 2008 | 2 | 4 | 6 |
| 2009 | 4 | 3 | 7 |
| 2010 | 4 | 6 | 10 |
| 2011 | 3 | 3 | 6 |
| 2012 | 4 | 7 | 11 |
| 2013 | 8 | 6 | 14 |
| 2014 | 12 | 6 | 18 |
| 2015 | 3 | 3 | 6 |
| 2016 | 4 | 4 | 8 |
| 2017 | 4 | 5 | 9 |
| 2018 | 3 | 1 | 4 |
| 2019 | 2 | 3 | 5 |
| 2020 | 2 | 4 | 6 |
| 2021 | 2 | 3 | 5 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Androstadienes" by people in Profiles.
-
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease. Ann Intern Med. 2023 08; 176(8):1047-1056.
-
Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial. Int J Chron Obstruct Pulmon Dis. 2022; 17:2043-2052.
-
Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management. J Allergy Clin Immunol Pract. 2022 11; 10(11):2904-2913.e6.
-
Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation. Int J Chron Obstruct Pulmon Dis. 2022; 17:491-504.
-
Safety of ciclesonide in children with asthma: A review of randomized controlled trials. Allergy Asthma Proc. 2021 11 01; 42(6):471-480.
-
Symptom control in patients with asthma using inhaled corticosteroids/long-acting ß2-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study. J Asthma. 2022 09; 59(9):1805-1818.
-
Interaction Between SNP Genotype and Efficacy of Anastrozole and Exemestane in Early-Stage Breast Cancer. Clin Pharmacol Ther. 2021 10; 110(4):1038-1049.
-
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET). Clin Cancer Res. 2021 06 15; 27(12):3443-3455.
-
Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials. Eur Respir J. 2021 03; 57(3).
-
Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2- Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1). Clin Cancer Res. 2021 08 01; 27(15):4177-4185.